[1] Bender E C,Tareq H S,Suggs L J.Inflammation: a matter of immune cell life and death[J]. npj Biomed Innov, 2025,2:7. [2] Choi B,Lee C,Yu J W.Distinctive role of inflammation in tissue repair and regeneration[J]. Arch Pharm Res, 2023,46(2):78-89. [3] Michalak K P,Michalak A Z.Understanding chronic inflammation: couplings between cytokines,ROS,NO, Cai2+,HIF-1α,Nrf2 and autophagy[J]. Front Immunol, 2025,16:1558263. [4] Chen L L,Deng H D,Cui H M,et al.Inflammatory responses and inflammation-associated diseases in organs[J]. Oncotarget,2018,9(6):7204-7218. [5] Cacciatore S,Andaloro S,Bernardi M,et al.Chronic inflammatory diseases and cardiovascular risk: current insights and future strategies for optimal management[J]. Int J Mol Sci,2025,26(7):3071. [6] Yi M,Li T Y,Niu M K,et al.Targeting cytokine and chemokine signaling pathways for cancer therapy[J]. Sig Transduct Target Ther,2024,9(1):176. [7] Hortová-Kohoutková M,Lázničková P,Frič J.How immune-cell fate and function are determined by metabolic pathway choice: The bioenergetics underlying the immune response[J]. Bioessays,2021,43(2):e2000067. [8] Chi H B.Immunometabolism at the intersection of metabolic signaling,cell fate,and systems immunology[J]. Cell Mol Immunol,2022,19(3):299-302. [9] Wang C L,Zhang W,Shu Y,et al.Metabolic control of immunity and inflammation: Mitochondrial dynamics, pharmacological targets,and therapeutic opportunities[J]. Pharmacol Res,2026,227:108194. [10] Hu T Y,Liu C H,Lei M,et al.Metabolic regulation of the immune system in health and diseases: mechanisms and interventions[J]. Sig Transduct Target Ther,2024,9(1):268. [11] Mathis D,Shoelson S E.Immunometabolism: an emerging frontier[J]. Nat Rev Immunol,2011,11(2):81-83. [12] Martinez-Santibañez G,Nien-Kai Lumeng C. Macrophages and the regulation of adipose tissue remodeling[J]. Annu Rev Nutr,2014,34:57-76. [13] Ito A,Suganami T.Lipid metabolism in myeloid cell function and chronic inflammatory diseases[J]. Front Immunol,2024,15:1495853. [14] Cheng S L,Xie L Y,Wu J B,et al.Lipid metabolism: a molecular switch to control inflammation[J]. Int Immunopharmacol,2026,173:116294. [15] Rao Z B,Liu S R,Li Z C,et al. Alarmin-loaded extracellular lipid droplets induce airway neutrophil infiltration during type 2 inflammation[J]. Immunity, 2024,57(11):2514-2529.e7. [16] Johnson A R,Qin Y Y,Cozzo A J,et al.Metabolic reprogramming through fatty acid transport protein 1 (FATP1) regulates macrophage inflammatory potential and adipose inflammation[J]. Mol Metab,2016,5(7): 506-526. [17] Huang D Q,Li H,Luo Y Q,et al.PLIN2-PGAM5-regulated lipid droplet-mitochondria contacts drive microglial neuroinflammation after spinal cord injury via fatty acid metabolic reprogramming[J]. Cell Death Differ,2026:1-18. [18] Li Z H,Deng W D,Yang L X,et al.Lipid metabolism in homeostasis and disease[J]. Sig Transduct Target Ther, 2026,11:55. [19] Petrenko V,Sinturel F,Riezman H,et al.Lipid metabolism around the body clocks[J]. Prog Lipid Res,2023,91: 101235. [20] Raeisi M,Yousefi M,Motavalli R,et al.Unpacking the lipid-immune axis in health and disease[J]. Immunol Cell Biol,2026,104(3):208-233. [21] Ito A.Lipid metabolic reprogramming in immune regulation and chronic inflammatory diseases[J]. Endocr J,2025,72(9):979-985. [22] Yi J,Zhou Q L,Huang J S,et al.Lipid metabolism disorder promotes the development of intervertebral disc degeneration[J]. Biomed Pharmacother,2023,166:115401. [23] 郑志茹,张尊建,许风国,等. 脂肪酸代谢在肾脏疾病中的作用及中药干预研究进展[J]. 中国药科大学学报,2023, 54(5):527-535. [24] Korbecki J,Bobiński R,Dutka M.Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors[J]. Inflamm Res,2019,68(6):443-458. [25] Huang S Z,Shangguan R N,Chen S Y,et al.Mechanism of fatty acid metabolism and regulation by lactate during exercise in white adipose and skeletal muscle tissue: a review[J]. Sports Med Open,2025,11(1):76. [26] Jin H R,Wang J,Wang Z J,et al.Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics[J]. J Hematol Oncol,2023, 16(1):103. [27] Chen Y L,Zhang J,Cui W G,et al.CD36,a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate[J]. J Exp Med,2022,219(6): e20211314. [28] Wu K Z,Lin F Z.Lipid metabolism as a potential target of liver cancer[J]. JHC,2024,11:327-346. [29] Li C L,Zhang L L,Qiu Z D,et al.Key molecules of fatty acid metabolism in gastric cancer[J]. Biomolecules,2022, 12(5):706. [30] Zhang M D,Ji J L,Lei Y Y,et al.Dual inhibition of hepatic ACLY and ACSS2: A synergistic approach to combat NAFLD through lipogenesis reduction and mitochondrial enhancement[J]. Pharmacol Res,2025, 215:107706. [31] Chen H D,Yang Z Y,Sun Y C,et al.Targeting the key enzymes of abnormal fatty acid β-oxidation as a potential strategy for tumor therapy[J]. Front Biosci (Landmark Ed),2022,27(3):95. [32] Sun S Y,Liu S,Ruan S Y,et al.Acetylation of CPT1A reduces fatty acid oxidation and leads to dysfunctional renal tubular mitochondria in diabetic kidney disease[J]. Biochem Pharmacol,2026,243(Pt 1):117465. [33] Ansari I H,Longacre M J,Stoker S W,et al.Characterization of Acyl-CoA synthetase isoforms in pancreatic beta cells: Gene silencing shows participation of ACSL3 and ACSL4 in insulin secretion[J]. Arch Biochem Biophys,2017,618:32-43. [34] Wang S L,Liu G H,Li Y R,et al.Metabolic reprogramming induces macrophage polarization in the tumor microenvironment[J]. Front Immunol,2022,13: 840029. [35] He Y H,Liu T T.Oxidized low-density lipoprotein regulates macrophage polarization in atherosclerosis[J]. Int Immunopharmacol,2023,120:110338. [36] Guo C Y,Islam R,Zhang S C,et al.Metabolic reprogramming of macrophages and its involvement in inflammatory diseases[J]. EXCLI J,2021,20:628-641. [37] Buck M D,O'Sullivan D,Pearce E L. T cell metabolism drives immunity[J]. J Exp Med,2015,212(9):1345-1360. [38] Hu Y H,Zhao Q H,Dai H R,et al.Metabolic reprogramming as a therapeutic target for modulating the Th17/Treg balance in autoimmune diseases: a comprehensive review[J]. Front Immunol,2025,16:1687755. [39] Yang L,Zhang C Y,Zhang Z X,et al.Targeting metabolic reprogramming to enhance adoptive immunotherapy: emerging mechanisms and translational perspectives[J]. J Transl Med,2026,24(1):476. [40] Yin M Y,Liang T,Zhang Y M,et al.Cholesterol metabolism in immune cells: From mechanisms to therapeutic opportunities[J]. Immunity,2026,59(6):1493-1511. [41] Aguilar-Ballester M,Herrero-Cervera A,Vinué Á, et al.Impact of cholesterol metabolism in immune cell function and atherosclerosis[J]. Nutrients,2020,12(7): 2021. [42] Bensinger S J,Bradley M N,Joseph S B,et al.LXR signaling couples sterol metabolism to proliferation in the acquired immune response[J]. Cell,2008,134(1): 97-111. [43] Kidani Y,Elsaesser H,Hock M B,et al.Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity[J]. Nat Immunol,2013,14(5):489-499. [44] Mosser D M,Edwards J P.Exploring the full spectrum of macrophage activation[J]. Nat Rev Immunol,2008, 8(12):958-969. [45] Liu J,Chen Y L,O'Neill L. Phospholipid metabolism in innate immunity and inflammation: from basic to clinic[J]. Immun Inflamm,2025,1:6. [46] O'Donnell V B,Rossjohn J,Wakelam M J O. Phospholipid signaling in innate immune cells[J]. J Clin Investig,2018,128(7):2670-2679. [47] Lands W E.Metabolism of glycerolipides;a comparison of lecithin and triglyceride synthesis[J]. J Biol Chem, 1958,231(2):883-888. [48] Harayama T,Eto M,Shindou H,et al.Lysophospholipid acyltransferases mediate phosphatidylcholine diversification to achieve the physical properties required in vivo[J]. Cell Metab,2014,20(2):295-305. [49] Hannun Y A,Obeid L M.Sphingolipids and their metabolism in physiology and disease[J]. Nat Rev Mol Cell Biol,2018,19(3):175-191. [50] Maceyka M,Spiegel S.Sphingolipid metabolites in inflammatory disease[J]. Nature,2014,510(7503):58-67. [51] Sun R,Gu X M,Lei C,et al.Neutral ceramidase-dependent regulation of macrophage metabolism directs intestinal immune homeostasis and controls enteric infection[J]. Cell Rep,2022,38(13):110560. [52] Harikumar K B,Yester J W,Surace M J,et al.K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5[J]. Nat Immunol,2014,15(3):231-238. [53] Joshi J C,Joshi B,Rochford I,et al. SPHK2-generated S1P in CD11b+ macrophages blocks STING to suppress the inflammatory function of alveolar macrophages[J]. Cell Rep,2020,30(12):4096-4109.e5. [54] Lau P,Zhang G X,Zhao S,et al.Sphingosine kinase 1 promotes tumor immune evasion by regulating the MTA3-PD-L1 axis[J]. Cell Mol Immunol,2022,19(10): 1153-1167. [55] York A G,Skadow M H,Oh J,et al.IL-10 constrains sphingolipid metabolism to limit inflammation[J]. Nature, 2024,627(8004):628-635. [56] Hubler M J,Kennedy A J.Role of lipids in the metabolism and activation of immune cells[J]. J Nutr Biochem,2016,34:1-7. [57] Green S M,Padula M P,Dodgen T M,et al.Lipidomic changes occurring in platelets during extended cold storage[J]. Transfus Med,2024,34(3):189-199. [58] Alabed H B R,Arcioni F,Pellegrino R M,et al. Lipidomic and metabolomic analysis of human erythrocytes during storage for transfusion applications[J]. Blood Transfus, 2026,24(4):313-324. [59] Xiang Y,Zhang M X,Jiang D,et al.The role of inflammation in autoimmune disease: a therapeutic target[J]. Front Immunol,2023,14:1267091. [60] Cui Y Y,Feng Z D,Zhao Q H,et al.Immunocyte lipid metabolic reprogramming: a novel pathway for targeted intervention in autoimmune diseases[J]. Front Immunol, 2025,16:1713148. [61] Kaul A,Gordon C,Crow M K,et al.Systemic lupus erythematosus[J]. Nat Rev Dis Primers,2016,2:16039. [62] Tsokos G C,Lo M S,Costa Reis P,et al.New insights into the immunopathogenesis of systemic lupus erythematosus[J]. Nat Rev Rheumatol,2016,12(12):716-730. [63] A-Gonzalez N,Bensinger S J,Hong C,et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR[J]. Immunity,2009,31(2):245-258. [64] Jeon J Y,Nam J Y,Kim H A,et al.Liver X receptors alpha gene (NR1H3) promoter polymorphisms are associated with systemic lupus erythematosus in Koreans[J]. Arthritis Res Ther,2014,16(3):R112. [65] Ito A,Hong C,Oka K,et al.Cholesterol accumulation in CD11c+ immune cells is a causal and targetable factor in autoimmune disease[J]. Immunity,2016,45(6):1311-1326. [66] Hu X,Wang Y H,Hao L Y,et al.Sterol metabolism controls T(H)17 differentiation by generating endogenous RORγ agonists[J]. Nat Chem Biol,2015,11(2):141-147. [67] Wahl D R,Petersen B,Warner R,et al.Characterization of the metabolic phenotype of chronically activated lymphocytes[J]. Lupus,2010,19(13):1492-1501. [68] Mohammadi S,Saghaeian-Jazi M,Sedighi S,et al.Immunomodulation in systemic lupus erythematosus: induction of M2 population in monocyte-derived macrophages by pioglitazone[J]. Lupus,2017,26(12): 1318-1327. [69] Toller-Kawahisa J E,Canicoba N C,Venancio V P,et al. Systemic lupus erythematosus onset in lupus-prone B6.MRL/lpr mice Is influenced by weight gain and Is preceded by an increase in neutrophil oxidative burst activity[J]. Free Radic Biol Med,2015,86:362-373. [70] de la Roche M,Hamilton C,Mortensen R,et al. Trafficking of cholesterol to the ER is required for NLRP3 inflammasome activation[J]. J Cell Biol,2018, 217(10):3560-3576. [71] Chawla A,Nguyen K D,Sharon Goh Y P. Macrophage-mediated inflammation in metabolic disease[J]. Nat Rev Immunol,2011,11(11):738-749. [72] Odegaard J I,Ricardo-Gonzalez R R,Goforth M H,et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance[J]. Nature, 2007,447(7148):1116-1120. [73] Stansbury C M,Dotson G A,Pugh H,et al.A lipid-associated macrophage lineage rewires the spatial landscape of adipose tissue in early obesity[J]. JCI Insight,2023,8(19):e171701. [74] Nakamura Y,Kulkarni N N,Takahashi T,et al.Increased LL37 in psoriasis and other inflammatory disorders promotes LDL uptake and atherosclerosis[J]. J Clin Invest,2024,134(5):e172578. [75] Jiang X C,Yu Y.The role of phospholipid transfer protein in the development of atherosclerosis[J]. Curr Atheroscler Rep,2021,23(3):9. [76] Oliveira-Paula G H,Liu S,Maira A,et al. The β-catenin C terminus links Wnt and sphingosine-1-phosphate signaling pathways to promote vascular remodeling and atherosclerosis[J]. Sci Adv,2024,10(11):eadg9278. [77] Bonilla M E,Radyk M D,Perricone M D,et al.Metabolic landscape of the healthy pancreas and pancreatic tumor microenvironment[J]. JCI Insight,2024,9(18):e180114. [78] 赵贤贤,孙茂允,李丹丹,等. 脂肪酸合酶在自身免疫性疾病中的作用机制研究进展[J]. 临床输血与检验,2025, 27(4):557-563. [79] 王凌霞,李晓,徐诗靓,等. 敲低Hsa_circ_0020080通过调节脂代谢对人乳腺癌细胞增殖、迁移及侵袭的促进作用[J]. 临床输血与检验,2025,27(1):34-48. |